PRM-151 clinical trials
Also written PRM-151.
How each study uses PRM-151 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses PRM-151 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisTerminatedPhase 3Hoffmann-La RocheNCT04594707Written as PRM-151 (Zinpentraxin Alfa)How we know
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisTerminatedPhase 3Hoffmann-La RocheNCT04552899Written as PRM-151 (Zinpentraxin Alfa)How we know
- A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedPhase 2Hoffmann-La RocheNCT02550873Written as PRM-151How we know
- PRM-151 in the Prevention of Scarring Following TrabeculectomyCompletedPhase 2Hoffmann-La RocheNCT01064817Written as PRM-151How we know
- A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedPhase 1Hoffmann-La RocheNCT01254409Written as PRM-151How we know
- A Phase 2 Study of RO7490677 In Participants With MyelofibrosisCompletedPhase 2Hoffmann-La RocheNCT01981850Written as RO7490677How we know